This report was recently updated on April 22 2024 with the latest and most recent
market numbers
Global Alopecia Market Size, Trends & Analysis - Forecasts to 2028 By Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, and Others), By Treatment (Pharmaceutical and Devices), By Gender (Male and Female), By Sales Channel (Prescriptions and OTS), By End-use (Homecare Settings and Dermatology Clinics), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
The global alopecia market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
Increased awareness about alopecia and the available treatment options are encouraging individuals to seek medical assistance for their hair loss concerns. The trend has been further supported by the readily available information on the internet and social media platforms.
The rising incidence of alopecia including androgenetic alopecia and alopecia areata, plays a crucial role in driving the market growth. Various factors contribute to this growing prevalence such as genetics, lifestyle changes, and environmental factors. Ongoing research and development endeavours in the field of alopecia have resulted in the introduction of cutting-edge and efficient treatment options. New medications, therapies, and technologies are offering improved outcomes for hair regrowth, attracting more patients to seek treatment.
In 2022, the U.S. Food and Drug Administration (FDA) approved Olumiant (baricitinib) oral tablets as a viable treatment choice for adult patients with severe alopecia areata. This approval marked a significant milestone in providing patients with an alternative therapeutic option to address the challenges posed by this hair loss condition.
According to NAAF, alopecia areata can start at any age. It predominantly occurs in the early stages of life for most individuals. Over 80% of people show indications of the disease before reaching 40 years of age, and around 40% experience symptoms even before turning 20. Moreover, the aging population is more susceptible to hair loss, particularly androgenetic alopecia, leading to a growing demand for hair loss treatments among the elderly.
Advancements in laser technology, hair transplant techniques, and other non-invasive procedures have improved the efficacy and safety of alopecia treatments, attracting more patients to opt for these services. According to the National Library of Medicine, low-level laser therapy (LLLT) has been recommended as a secure device-based approach to stimulate hair growth in both men and women affected by androgenetic alopecia (AGA).
Alopecia areata segment is expected to hold the largest share in the market during the forecast period. According to National Alopecia Areata Foundation alopecia areata affects a significant number of individuals, with around 6.7 million people in the U.S. and a staggering 160 million worldwide experiencing or expected to experience it at some point. This condition affects individuals of diverse ages, genders, and racial and ethnic backgrounds without any limitations. While the onset of hair loss frequently occurs during childhood, the timing and presentation vary from person to person, making each case unique. Currently, around 700,000 individuals in the U.S. are suffering with some form of alopecia areata.
Alopecia totalis and alopecia universalis are expected to be the fastest-growing segment in the market from 2023-2028. This growth is expected to be driven by two main factors. Firstly, there is a growing awareness of the severe impacts of alopecia, leading to an increased demand for effective treatments. Secondly, the research efforts aimed at developing novel and improved treatment options are gaining momentum, further boosting the market growth. In June 2023, Pfizer received the U.S. FDA approval for LITFULO (Ritlecitinib), an oral treatment designed for individuals aged 12 and above who have severe alopecia areata. This medication is taken once daily to address the condition effectively.
Pharmaceutical segment is expected to hold the largest share in the market during the forecast period. This is due to the affordability of pharmaceutical products and the widespread use of prescription and OTC drugs. Prominent pharmaceutical companies such as Lilly, Pfizer Inc., and Concert Pharmaceuticals are actively engaged in developing innovative drugs for alopecia treatment, which is expected to propel market growth in the foreseeable future. Additionally, Finasteride and minoxidil are the most commonly used drugs for treating all forms of alopecia, and they are the only drugs approved in the U.S. for both female pattern hair loss and male pattern hair loss.
Device segment is anticipated to be the fastest-growing segment in the market from 2023-2028. The growth is attributed to the increasing popularity of painless treatments with minimal side effects and the use of home-based laser devices. Low-level laser therapy allows people to use it conveniently at home, reducing the need for frequent clinical visits. This non-pharmacological and non-surgical approach for hair restoration is expected to drive the segment growth.
The dermatology clinics segment is anticipated to hold the largest share of the market. This is attributed to the adoption of modern treatment methods like laser technology, a promising product pipeline, and increased consumer awareness about prescription medicines. Consulting dermatologists, offering personalized medications and effective therapies, are preferred by patients for alopecia treatment due to their ability to deliver positive outcomes.
The home care segment is anticipated to be the fastest-growing segment in the market from 2023-2028. This is due to its convenience, user-friendliness, and patient satisfaction. Regulatory approvals for home-use devices and the increasing acceptance of non-invasive procedures like laser therapy, which require no major lifestyle adjustments, contribute to this growth trend. In 2020 Conversion Labs, Inc., a company specializing in direct-to-consumer telemedicine and wellness services obtained U.S. FDA clearance for its hair regrowth product, known as the Shapiro MD Laser Hair Restoration Device.
The male segment is expected to hold the largest share of the market. Androgenetic alopecia stands as the prevalent form of hair loss among males. Significant number of men experience hair loss to some extent at an average age of 50, and over 95% of these cases being of the androgenetic type. Additionally, factors such as increased tobacco consumption in men and a growing geriatric population are anticipated to drive the market growth during the forecast period.
The female segment is anticipated to be the fastest-growing segment in the market from 2023-2028. According to NAAD research, the probability of women developing alopecia areata surpasses that of men. Moreover, specific racial and ethnic groups are more likely to be impacted by this condition. These factors can significantly influence the occurrence of the disease within different population groups.
The prescription segment is expected to hold the largest share of the market. Many effective treatments for alopecia areata, such as Finasteride and Minoxidil, two common alopecia medications are needed to be prescribed by a healthcare professional due to potential side effects and for proper monitoring. Additionally, the segment's rapid growth during the forecast period is driven by a robust product pipeline, increasing disposable incomes, and a rising prevalence of chronic diseases that contribute to hair loss.
Furthermore, OTC drugs are the preferred choice for males dealing with androgenetic alopecia and other forms of hair loss, especially in cases where approved medications are lacking. Consumers often resort to off-label or OTC drugs due to the convenience and accessibility they offer in such situations. This increasing reliance on OTC options further contributes to the segment growth.
North American is expected to be the largest region in the global market. The regional growth is attributed to high prevalence of hair loss, advanced healthcare infrastructure offering a wide array of treatment options, technological advancements in medical research related to Alopecia, and higher healthcare expenditure. Additionally, the involvement of government and non-profit organizations such as the National Alopecia Areata Foundation (NAAF) and Canadian Alopecia Areata Foundation, plays a significant role in shaping the market. These organizations propose guidelines and promote awareness among the public, which is expected to positively influence the market growth.
Asia Pacific is anticipated to witness rapid growth during the forecast period. This is due to the factors such as region's large and growing population, especially in China and India, presents a substantial patient pool for alopecia treatment. Additionally, increasing disposable income and changing lifestyles of the population, along with a growing awareness of hair loss issues, are expected to drive the regional market growth.
Johnson & Johnson Services, Inc, Merck & Co., Inc., Cipla Limited, Sun Pharmaceuticals Industries Ltd, Dr. Reddy's Laboratories Ltd, GlaxoSmithKline plc.; Aurobindo Pharma, Viatris Inc., Pfizer, Inc., Lilly, and Lexington Intl., LLC (Devices) among others, are some of the key players operating in the global alopecia market.
Please note: This is not an exhaustive list of companies profiled in the report.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
2.4 Data Metrics
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
4 GLOBAL ALOPECIA MARKET, BY DISEASE TYPE
4.2 Alopecia Market: Disease Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4.1 Alopecia Areata Market Estimates and Forecast, 2020-2028 (USD Million)
4.5.1 Cicatricial Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
4.6.1 Traction Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
4.7.1 Alopecia Totalis Market Estimates and Forecast, 2020-2028 (USD Million)
4.8.1 Alopecia Universalis Market Estimates and Forecast, 2020-2028 (USD Million)
4.9.1 Androgenetic Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
4.10.1 Others Market Estimates and Forecast, 2020-2028 (USD Million)
5 GLOBAL ALOPECIA MARKET, BY TREATMENT
5.2 Alopecia Market: Treatment Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4.1 Pharmaceuticals Market Estimates and Forecast, 2020-2028 (USD Million)
5.5.1 Devices Market Estimates and Forecast, 2020-2028 (USD Million)
6 GLOBAL ALOPECIA MARKET, BY GENDER
6.2 Alopecia Market: Gender Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4.1 Male Market Estimates and Forecast, 2020-2028 (USD Million)
6.5.1 Female Market Estimates and Forecast, 2020-2028 (USD Million)
7 GLOBAL ALOPECIA MARKET, BY SALES CHANNEL
7.2 Alopecia Market: Sales Channel Scope Key Takeaways
7.3 Revenue Growth Analysis, 2022 & 2028
7.4.1 Prescriptions Market Estimates and Forecast, 2020-2028 (USD Million)
7.5.1 OTC Market Estimates and Forecast, 2020-2028 (USD Million)
8 GLOBAL ALOPECIA MARKET, BY END-USE
8.2 Alopecia Market: End User Scope Key Takeaways
8.3 Revenue Growth Analysis, 2022 & 2028
8.4.1 Homecare Settings Market Estimates and Forecast, 2020-2028 (USD Million)
8.5.1 Dermatology Clinics Market Estimates and Forecast, 2020-2028 (USD Million)
9 GLOBAL ALOPECIA MARKET, BY REGION
9.2 North America Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.2.6.1 U.S. Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.2.6.2 Canada Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.2.6.3 Mexico Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.3 Europe Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.3.6.1 Germany Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.3.6.2 U.K. Presered Flowers Market Estimates and Forecast, 2020-2028 (USD Million)
9.3.6.3 France Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.3.6.4 Italy Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.3.6.5 Spain Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.3.6.6 Netherlands Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.3.6.7 Rest of Europe Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4 Asia Pacific Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.1 China Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.2 Japan Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.3 India Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.4 South Korea Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.5 Singapore Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.6 Malaysia Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.7 Thailand Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.8 Indonesia Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.9 Vietnam Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.10 Taiwan Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.4.6.11 Rest of Asia Pacific Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.5 Middle East and Africa Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.5.6.1 Saudi Arabia Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.5.6.2 U.A.E. Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.5.6.3 Israel Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.5.6.4 South Africa Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.6 Central and South America Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.6.6.1 Brazil Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.6.6.2 Argentina Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
9.6.6.3 Chile Alopecia Market Estimates and Forecast, 2020-2028 (USD Million)
10.1 Company Market Share Analysis
10.2 Four Quadrant Positioning Matrix
10.4.1 Johnson & Johnson Services, Inc
10.4.1.1 Business Description & Financial Analysis
10.4.1.3 Poducts & Services Offered
10.4.1.4 Strategic Alliances between Business Partners
10.4.2.1 Business Description & Financial Analysis
10.4.2.3 Poducts & Services Offered
10.4.2.4 Strategic Alliances between Business Partners
10.4.3.1 Business Description & Financial Analysis
10.4.3.3 Poducts & Services Offered
10.4.3.4 Strategic Alliances between Business Partners
10.4.4 Sun Pharmaceuticals Industries Ltd
10.4.4.1 Business Description & Financial Analysis
10.4.4.3 Poducts & Services Offered
10.4.4.4 Strategic Alliances between Business Partners
10.4.5 Dr. Reddy’s Laboratories Ltd
10.4.5.1 Business Description & Financial Analysis
10.4.5.3 Poducts & Services Offered
10.4.5.4 Strategic Alliances between Business Partners
10.4.6.1 Business Description & Financial Analysis
10.4.6.3 Poducts & Services Offered
10.4.6.4 Strategic Alliances between Business Partners
10.4.7.1 Business Description & Financial Analysis
10.4.7.3 Poducts & Services Offered
10.4.7.4 Strategic Alliances between Business Partners
10.4.8.1 Business Description & Financial Analysis
10.4.8.3 Poducts & Services Offered
10.4.8.4 Strategic Alliances between Business Partners
10.4.9 Lexington Intl., LLC (Devices)
10.4.9.1 Business Description & Financial Analysis
10.4.9.3 Poducts & Services Offered
10.4.9.4 Strategic Alliances between Business Partners
10.4.10 Freedom Laser Therapy (iRestore ID-520 helmet)
10.4.10.1 Business Description & Financial Analysis
10.4.10.3 Poducts & Services Offered
10.4.10.4 Strategic Alliances between Business Partners
10.4.11.1 Business Description & Financial Analysis
10.4.11.3 Poducts & Services Offered
10.4.11.4 Strategic Alliances between Business Partners
11.1.2 Market Scope & SegCicatricial Alopeciatation
11.2 Information ProcureCicatricial Alopeciat
11.2.1.2 GMEs Internal Data Repository
11.2.1.3 Secondary Resources & Third Party Perspectives
11.2.1.4 Company Information Sources
11.2.2.1 Various Types of Respondents for Primary Interviews
11.2.2.2 Number of Interviews Conducted throughout the Research Process
11.2.2.4 Discussion Guide for Primary Participants
11.2.3.1 Expert Panels Across 30+ Industry
11.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
11.3.1.1 Macro-Economic Indicators Considered
11.3.1.2 Micro-Economic Indicators Considered
11.3.2.1 Company Share Analysis Approach
11.3.2.2 Estimation of Potential End User Sales
11.4.2 Time Series, Cross Sectional & Panel Data Analysis
11.5.1 Inhouse AI Based Real Time Analytics Tool
11.5.2 Output From Desk & Primary Research
11.6 Research Assumptions & Limitations
LIST OF TABLES
1 Global Alopecia Market, By Disease Type, 2020-2028 (USD Mllion)
2 Alopecia Areata Market, By Region, 2020-2028 (USD Mllion)
3 Cicatricial Alopecia Market, By Region, 2020-2028 (USD Mllion)
4 Traction Alopecia Market, By Region, 2020-2028 (USD Mllion)
5 Alopecia Totalis Market, By Region, 2020-2028 (USD Mllion)
6 Alopecia Universalis Market, By Region, 2020-2028 (USD Mllion)
7 Androgenetic Alopecia Market, By Region, 2020-2028 (USD Mllion)
8 others Market, By Region, 2020-2028 (USD Mllion)
9 Global Alopecia Market, By Treatment, 2020-2028 (USD Mllion)
10 Pharmaceuticals Market, By Region, 2020-2028 (USD Mllion)
11 Devices Market, By Region, 2020-2028 (USD Mllion)
12 Global Alopecia Market, By Gender, 2020-2028 (USD Mllion)
13 Male Market, By Region, 2020-2028 (USD Mllion)
14 Female Market, By Region, 2020-2028 (USD Mllion)
15 Global Alopecia Market, By Sales Channel, 2020-2028 (USD Mllion)
16 Prescriptions Market, By Region, 2020-2028 (USD Mllion)
17 OTC Market, By Region, 2020-2028 (USD Mllion)
18 Global Alopecia Market, By End-use, 2020-2028 (USD Mllion)
19 Homecare Settings Market, By Region, 2020-2028 (USD Mllion)
20 Dermatology Clinics Market, By Region, 2020-2028 (USD Mllion)
21 Regional Analysis, 2020-2028 (USD Mllion)
22 North America Alopecia Market, By Disease Type, 2020-2028 (USD Million)
23 North America Alopecia Market, By Treatment, 2020-2028 (USD Million)
24 North America Alopecia Market, By Gender, 2020-2028 (USD Million)
25 North America Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
26 North America Alopecia Market, By Country, 2020-2028 (USD Million)
27 North America Alopecia Market, By End-use, 2020-2028 (USD Million)
28 U.S Alopecia Market, By Disease Type, 2020-2028 (USD Million)
29 U.S Alopecia Market, By Treatment, 2020-2028 (USD Million)
30 U.S Alopecia Market, By Gender, 2020-2028 (USD Million)
31 U.S Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
32 U.S America Alopecia Market, By End-use, 2020-2028 (USD Million)
33 Canada Alopecia Market, By Disease Type, 2020-2028 (USD Million)
34 Canada Alopecia Market, By Treatment, 2020-2028 (USD Million)
35 Canada Alopecia Market, By Gender, 2020-2028 (USD Million)
36 CANADA Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
37 CANADA Alopecia Market, By End-use, 2020-2028 (USD Million)
38 Mexico Alopecia Market, By Disease Type, 2020-2028 (USD Million)
39 Mexico Alopecia Market, By Treatment, 2020-2028 (USD Million)
40 Mexico Alopecia Market, By Gender, 2020-2028 (USD Million)
41 mexico Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
42 MEXICO Alopecia Market, By End-use, 2020-2028 (USD Million)
43 Europe Alopecia Market, By Disease Type, 2020-2028 (USD Million)
44 Europe Alopecia Market, By Treatment, 2020-2028 (USD Million)
45 Europe Alopecia Market, By Gender, 2020-2028 (USD Million)
46 europe Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
47 EUROPE Alopecia Market, By End-use, 2020-2028 (USD Million)
48 Germany Alopecia Market, By Disease Type, 2020-2028 (USD Million)
49 Germany Alopecia Market, By Treatment, 2020-2028 (USD Million)
50 Germany Alopecia Market, By Gender, 2020-2028 (USD Million)
51 germany Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
52 GERMANY Alopecia Market, By End-use, 2020-2028 (USD Million)
53 UK Alopecia Market, By Disease Type, 2020-2028 (USD Million)
54 UK Alopecia Market, By Treatment, 2020-2028 (USD Million)
55 UK Alopecia Market, By Gender, 2020-2028 (USD Million)
56 U.k Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
57 U.K Alopecia Market, By End-use, 2020-2028 (USD Million)
58 France Alopecia Market, By Disease Type, 2020-2028 (USD Million)
59 France Alopecia Market, By Treatment, 2020-2028 (USD Million)
60 France Alopecia Market, By Gender, 2020-2028 (USD Million)
61 france Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
62 FRANCE Alopecia Market, By End-use, 2020-2028 (USD Million)
63 Italy Alopecia Market, By Disease Type, 2020-2028 (USD Million)
64 Italy Alopecia Market, By Treatment, 2020-2028 (USD Million)
65 Italy Alopecia Market, By Gender, 2020-2028 (USD Million)
66 italy Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
67 ITALY Alopecia Market, By End-use, 2020-2028 (USD Million)
68 Spain Alopecia Market, By Disease Type, 2020-2028 (USD Million)
69 Spain Alopecia Market, By Treatment, 2020-2028 (USD Million)
70 Spain Alopecia Market, By Gender, 2020-2028 (USD Million)
71 spain Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
72 SPAIN Alopecia Market, By End-use, 2020-2028 (USD Million)
73 Rest Of Europe Alopecia Market, By Disease Type, 2020-2028 (USD Million)
74 Rest Of Europe Alopecia Market, By Treatment, 2020-2028 (USD Million)
75 Rest of Europe Alopecia Market, By Gender, 2020-2028 (USD Million)
76 REST OF EUROPE Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
77 REST OF EUROPE Alopecia Market, By End-use, 2020-2028 (USD Million)
78 Asia Pacific Alopecia Market, By Disease Type, 2020-2028 (USD Million)
79 Asia Pacific Alopecia Market, By Treatment, 2020-2028 (USD Million)
80 Asia Pacific Alopecia Market, By Gender, 2020-2028 (USD Million)
81 asia Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
82 Asia Pacific Alopecia Market, By Country, 2020-2028 (USD Million)
83 ASIA PACIFIC Alopecia Market, By End-use, 2020-2028 (USD Million)
84 China Alopecia Market, By Disease Type, 2020-2028 (USD Million)
85 China Alopecia Market, By Treatment, 2020-2028 (USD Million)
86 China Alopecia Market, By Gender, 2020-2028 (USD Million)
87 china Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
88 CHINA Alopecia Market, By End-use, 2020-2028 (USD Million)
89 India Alopecia Market, By Disease Type, 2020-2028 (USD Million)
90 India Alopecia Market, By Treatment, 2020-2028 (USD Million)
91 India Alopecia Market, By Gender, 2020-2028 (USD Million)
92 india Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
93 INDIA Alopecia Market, By End-use, 2020-2028 (USD Million)
94 Japan Alopecia Market, By Disease Type, 2020-2028 (USD Million)
95 Japan Alopecia Market, By Treatment, 2020-2028 (USD Million)
96 Japan Alopecia Market, By Gender, 2020-2028 (USD Million)
97 japan Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
98 JAPAN Alopecia Market, By End-use, 2020-2028 (USD Million)
99 South Korea Alopecia Market, By Disease Type, 2020-2028 (USD Million)
100 South Korea Alopecia Market, By Treatment, 2020-2028 (USD Million)
101 South Korea Alopecia Market, By Gender, 2020-2028 (USD Million)
102 south korea Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
103 SOUTH KOREA Alopecia Market, By End-use, 2020-2028 (USD Million)
104 Middle East and Africa Alopecia Market, By Disease Type, 2020-2028 (USD Million)
105 Middle East and Africa Alopecia Market, By Treatment, 2020-2028 (USD Million)
106 Middle East and Africa Alopecia Market, By Gender, 2020-2028 (USD Million)
107 MIDDLE EAST AND AFRICA Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
108 Middle East and Africa Alopecia Market, By Country, 2020-2028 (USD Million)
109 MIDDLE EAST AND AFRICA Alopecia Market, By End-use, 2020-2028 (USD Million)
110 Saudi Arabia Alopecia Market, By Disease Type, 2020-2028 (USD Million)
111 Saudi Arabia Alopecia Market, By Treatment, 2020-2028 (USD Million)
112 Saudi Arabia Alopecia Market, By Gender, 2020-2028 (USD Million)
113 saudi arabia Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
114 SAUDI ARABIA Alopecia Market, By End-use, 2020-2028 (USD Million)
115 UAE Alopecia Market, By Disease Type, 2020-2028 (USD Million)
116 UAE Alopecia Market, By Treatment, 2020-2028 (USD Million)
117 UAE Alopecia Market, By Gender, 2020-2028 (USD Million)
118 uae Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
119 UAE Alopecia Market, By End-use, 2020-2028 (USD Million)
120 Central and South America Alopecia Market, By Disease Type, 2020-2028 (USD Million)
121 Central and South America Alopecia Market, By Treatment, 2020-2028 (USD Million)
122 Central and South America Alopecia Market, By Gender, 2020-2028 (USD Million)
123 CENTRAL AND SOUTH AMERICA Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
124 Central and South America Alopecia Market, By Country, 2020-2028 (USD Million)
125 CENTRAL AND SOUTH AMERICA Alopecia Market, By End-use, 2020-2028 (USD Million)
126 Brazil Alopecia Market, By Disease Type, 2020-2028 (USD Million)
127 Brazil Alopecia Market, By Treatment, 2020-2028 (USD Million)
128 Brazil Alopecia Market, By Gender, 2020-2028 (USD Million)
129 brazil Alopecia Market, By Sales Channel, 2020-2028 (USD Million)
130 BRAZIL Alopecia Market, By End-use, 2020-2028 (USD Million)
131 Johnson & Johnson Services, Inc: PRODUCTS & SERVICES OFFERING
132 Merck & Co., Inc.: PRODUCTS & SERVICES OFFERING
133 Cipla Limited: PRODUCTS & SERVICES OFFERING
134 Sun Pharmaceuticals Industries Ltd: PRODUCTS & SERVICES OFFERING
135 Dr. Reddy’s Laboratories Ltd: PRODUCTS & SERVICES OFFERING
136 LILLY: PRODUCTS & SERVICES OFFERING
137 Viatris Inc. : PRODUCTS & SERVICES OFFERING
138 Pfizer, Inc.: PRODUCTS & SERVICES OFFERING
139 Lexington Intl., LLC (Devices), Inc: PRODUCTS & SERVICES OFFERING
140 Freedom Laser Therapy (iRestore ID-520 helmet): PRODUCTS & SERVICES OFFERING
141 Other Companies: PRODUCTS & SERVICES OFFERING
LIST OF FIGURES
1 Global Alopecia Market Overview
2 Global Alopecia Market Value From 2020-2028 (USD Mllion)
3 Global Alopecia Market Share, By Disease Type (2022)
4 Global Alopecia Market Share, By Treatment (2022)
5 Global Alopecia Market Share, By Gender (2022)
6 Global Alopecia Market Share, By Sales Channel (2022)
7 Global Alopecia Market Share, By End-use (2022)
8 Global Alopecia Market, By Region (Asia Pacific Market)
9 Technological Trends In Global Alopecia Market
10 Four Quadrant Competitor Positioning Matrix
11 Impact Of Macro & Micro Indicators On The Market
12 Impact Of Key Drivers On The Global Alopecia Market
13 Impact Of Challenges On The Global Alopecia Market
14 Porter’s Five Forces Analysis
15 Global Alopecia Market: By Disease Type Scope Key Takeaways
16 Global Alopecia Market, By Disease Type Segment: Revenue Growth Analysis
17 Alopecia Areata Market, By Region, 2020-2028 (USD Mllion)
18 Cicatricial Alopecia Market, By Region, 2020-2028 (USD Mllion)
19 Traction Alopecia Market, By Region, 2020-2028 (USD Mllion)
20 Alopecia Totalis Market, By Region, 2020-2028 (USD Mllion)
21 Alopecia Universalis Market, By Region, 2020-2028 (USD Mllion)
22 Androgenetic Alopecia Market, By Region, 2020-2028 (USD Mllion)
23 Others Market, By Region, 2020-2028 (USD Mllion)
24 Global Alopecia Market: By Treatment Scope Key Takeaways
25 Global Alopecia Market, By Treatment Segment: Revenue Growth Analysis
26 Pharmaceuticals Market, By Region, 2020-2028 (USD Mllion)
27 Devices Market, By Region, 2020-2028 (USD Mllion)
28 Global Alopecia Market: By Gender Scope Key Takeaways
29 Global Alopecia Market, By Gender Segment: Revenue Growth Analysis
30 Male Market, By Region, 2020-2028 (USD Mllion)
31 Female Market, By Region, 2020-2028 (USD Mllion)
32 Global Alopecia Market: By Sales Channel Scope Key Takeaways
33 Global Alopecia Market, By Sales Channel Segment: Revenue Growth Analysis
34 Prescriptions Market, By Region, 2020-2028 (USD Mllion)
35 OTC Market, By Region, 2020-2028 (USD Mllion)
36 Global Alopecia Market: By End-use Scope Key Takeaways
37 Global Alopecia Market, By End-use Segment: Revenue Growth Analysis
38 Homecare Settings Market, By Region, 2020-2028 (USD Mllion)
39 Dermatology Clinics Market, By Region, 2020-2028 (USD Mllion)
40 Reference Laboratories Market, By Region, 2020-2028 (USD Mllion)
41 Other End Users Market, By Region, 2020-2028 (USD Mllion)
42 Regional Segment: Revenue Growth Analysis
43 Global Alopecia Market: Regional Analysis
44 North America Alopecia Market Overview
45 North America Alopecia Market, By Disease Type
46 North America Alopecia Market, By Treatment
47 North America Alopecia Market, By Gender
48 North America Alopecia Market, By Sales Channel
49 North America Alopecia Market, By End-use
50 North America Alopecia Market, By Country
51 U.S. Alopecia Market, By Disease Type
52 U.S. Alopecia Market, By Treatment
53 U.S. Alopecia Market, By Gender
54 U.S. Alopecia Market, By Sales Channel
55 U.S. Alopecia Market, By End-use
56 Canada Alopecia Market, By Disease Type
57 Canada Alopecia Market, By Treatment
58 Canada Alopecia Market, By Gender
59 Canada Alopecia Market, By Sales Channel
60 Canada Alopecia Market, By End-use
61 Mexico Alopecia Market, By Disease Type
62 Mexico Alopecia Market, By Treatment
63 Mexico Alopecia Market, By Gender
64 Mexico Alopecia Market, By Sales Channel
65 Mexico Alopecia Market, By End-use
66 Four Quadrant Positioning Matrix
67 Company Market Share Analysis
68 Johnson & Johnson Services, Inc: Company Snapshot
69 Johnson & Johnson Services, Inc: SWOT Analysis
70 Johnson & Johnson Services, Inc: Geographic Presence
71 Merck & Co., Inc.: Company Snapshot
72 Merck & Co., Inc.: SWOT Analysis
73 Merck & Co., Inc.: Geographic Presence
74 Cipla Limited: Company Snapshot
75 Cipla Limited: SWOT Analysis
76 Cipla Limited: Geographic Presence
77 Sun Pharmaceuticals Industries Ltd: Company Snapshot
78 Sun Pharmaceuticals Industries Ltd: Swot Analysis
79 Sun Pharmaceuticals Industries Ltd: Geographic Presence
80 Dr. Reddy’s Laboratories Ltd: Company Snapshot
81 Dr. Reddy’s Laboratories Ltd: SWOT Analysis
82 Dr. Reddy’s Laboratories Ltd: Geographic Presence
83 Lilly: Company Snapshot
84 Lilly: SWOT Analysis
85 Lilly: Geographic Presence
86 Viatris Inc. : Company Snapshot
87 Viatris Inc. : SWOT Analysis
88 Viatris Inc. : Geographic Presence
89 Pfizer, Inc.: Company Snapshot
90 Pfizer, Inc.: SWOT Analysis
91 Pfizer, Inc.: Geographic Presence
92 Lexington Intl., LLC (Devices), Inc.: Company Snapshot
93 Lexington Intl., LLC (Devices), Inc.: SWOT Analysis
94 Lexington Intl., LLC (Devices), Inc.: Geographic Presence
95 Freedom Laser Therapy (iRestore ID-520 helmet): Company Snapshot
96 Freedom Laser Therapy (iRestore ID-520 helmet): SWOT Analysis
97 Freedom Laser Therapy (iRestore ID-520 helmet): Geographic Presence
98 Other Companies: Company Snapshot
99 Other Companies: SWOT Analysis
100 Other Companies: Geographic Presence
The Global Alopecia Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Alopecia Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
